Does Remicade Trigger Lupus-Like Syndrome?
Yes, Remicade (infliximab), a TNF-alpha inhibitor used for autoimmune conditions like rheumatoid arthritis and Crohn's disease, can cause drug-induced lupus-like syndrome (DIL). This occurs in 0.5-1% of patients, typically resolving after stopping the drug.[1][2]
How Does It Happen?
Remicade blocks TNF-alpha, which normally regulates immune responses. This can lead to autoantibody production, including anti-nuclear antibodies (ANA) in up to 50% of users and anti-double-stranded DNA antibodies in 10-20%. Only a subset develop full DIL symptoms like rash, arthritis, serositis, or fever.[1][3]
Common Symptoms Patients Report
- Joint pain or swelling mimicking lupus arthritis
- Skin rashes, often malar (butterfly rash)
- Fatigue, mouth ulcers, or pleuritis
Symptoms appear after months of treatment and fade within weeks to months post-discontinuation.[2][4]
How Rare Is It Compared to Other Biologics?
Less common than with older drugs like procainamide (20% risk) but similar to other anti-TNFs like Humira (adalimumab) or Enbrel (etanercept), where DIL rates range 0.2-1.5%. Unlike idiopathic lupus, DIL rarely affects kidneys or brain.[1][3]
What Do Doctors Do If It Happens?
Switch to a non-TNF biologic like rituximab. Most cases reverse without lasting damage; steroids help symptoms. Label warns of 'lupus-like syndrome'—monitor ANA/anti-dsDNA if symptoms arise.[2][5]
Risk Factors and Who Gets It?
Higher in women, those with pre-existing autoantibodies, or prolonged use. Not linked to dose. Screen with baseline ANA if high-risk.[3][4]
[1]: FDA Remicade Label
[2]: Arthritis Foundation on Drug-Induced Lupus
[3]: UpToDate: Anti-TNF Adverse Effects
[4]: PubMed Review: Infliximab-Induced Lupus
[5]: Drugs.com Remicade Side Effects